CVS Group plc Exercise of Options and Total Voting Rights (4231E)
June 30 2023 - 2:00AM
UK Regulatory
TIDMCVSG
RNS Number : 4231E
CVS Group plc
30 June 2023
30 June 2023
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary
services, confirms that certain employees have exercised options
during June under the CVS Group 2019 SAYE Plan (2019/2023)
totalling 13,458 ordinary shares of 0.2 pence each ("Ordinary
Shares").
The sum of 13,458 new Ordinary Shares were issued to satisfy the
balance of Ordinary Shares arising from the SAYE Exercise.
Admission of the 13,458 new Ordinary Shares has been satisfied by
the Company's block listing admitted to the London Stock Exchange
on 30 December 2021.
Following the issue of these new Ordinary Shares, which rank
pari passu in all respects with the Company's existing Ordinary
Shares, the Company has a total issued share capital of 71,423,902
Ordinary Shares, each carrying one voting right. The Company holds
no Ordinary Shares in treasury and the total number of voting
rights is therefore 71,423,902.
This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required
to notify their interest, or a change to their interest, in the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
Contacts:
CVS Group plc
via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418
8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane
+44 (0)7733 124 226
Ginny Pulbrook
+44 (0)7961 315 138
About CVS Group plc ( www.cvsukltd.co.uk )
CVS Group is an AIM-quoted fully-integrated provider of
veterinary services in the UK, with practices in the Netherlands
and the Republic of Ireland. CVS is focused on providing high
quality clinical services to its customers and their animals, with
outstanding and dedicated clinical teams and support colleagues at
the core of its strategy.
The Group has c.500 veterinary practices across its three
markets, including eight specialist referral hospitals and 37
dedicated out-of-hours sites. Alongside the core Veterinary
Practices division, CVS operates Laboratories (providing diagnostic
services to CVS and third-parties), Crematoria (providing pet
cremation and clinical waste disposal for CVS and third-party
practices), Buying Groups and the Group's online retail business
("Animed Direct").
The Group employs c.8,500 personnel, including c.2,200
veterinary surgeons and c.3,100 nurses.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEBDGDLIUDDGXC
(END) Dow Jones Newswires
June 30, 2023 02:00 ET (06:00 GMT)
CVS (AQSE:CVSG.GB)
Historical Stock Chart
From Jul 2024 to Aug 2024
CVS (AQSE:CVSG.GB)
Historical Stock Chart
From Aug 2023 to Aug 2024